|
End-of-day quote
Bucharest S.E.
|
||
| - RON | - |
|
| 05-29 | S.C. Ropharma S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-28 | S.C. Ropharma S.A. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 117M 25.68M 22.25M 20.85M 19.01M 35.75M 2.45B 36.3M 245M 95.84M 1.23B 96.42M 94.33M 4.09B | P/E 2024 |
-47.7x | P/E 2025 | 45x |
|---|---|---|---|---|---|
| Enterprise Value | 228M 50.15M 43.45M 40.71M 37.13M 69.81M 4.78B 70.88M 479M 187M 2.4B 188M 184M 7.99B | EV / Sales 2024 |
0.17x | EV / Sales 2025 | 0.13x |
| Free-Float |
34.75% | Yield 2024 * |
-
| Yield 2025 | - |
| 28/04/22 | S C Ropharma S A : OGSM & EGSM resolutions 28.04.2022 | PU |
| 23/03/22 | S C Ropharma S A : Notice of O&EGSM 28.04.2022 | PU |
| 27/01/22 | S C Ropharma S A : 2022 Financial calendar | PU |
| Manager | Title | Age | Since |
|---|---|---|---|
Mihai Miron
CEO | Chief Executive Officer | 65 | - |
| Director of Finance/CFO | 54 | 01/01/2010 | |
Danut-Marian Ene
HRO | Human Resources Officer | 58 | 01/01/2012 |
| Director | Title | Age | Since |
|---|---|---|---|
Mihai Miron
CHM | Chairman | 65 | 01/01/2009 |
| Director/Board Member | 54 | 01/01/2007 | |
Florentina Miron
BRD | Director/Board Member | 70 | 01/01/2007 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.06% | +1.42% | +5.21% | +11.00% | 6.9B | |
| +0.37% | +3.07% | -34.88% | -23.78% | 3.23B | |
| +0.95% | +3.97% | -27.86% | +29.44% | 3.18B | |
| +1.16% | +2.20% | -21.62% | -13.45% | 2.73B | |
| -0.17% | +0.53% | -5.40% | +35.96% | 2.4B | |
| -2.78% | +7.50% | -26.50% | -37.12% | 1.58B | |
| +0.61% | +1.69% | -7.27% | -8.17% | 1.34B | |
| +0.70% | +3.87% | +28.32% | +56.03% | 504M | |
| +3.14% | +26.67% | -6.79% | +0.73% | 400M | |
| Average | +0.44% | +4.90% | -10.75% | +5.63% | 2.47B | |
| Weighted average by Cap. | +0.21% | +1.51% | -12.46% | +4.56% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.32B 292M 253M 237M 216M 406M 27.8B 412M 2.78B 1.09B 13.92B 1.09B 1.07B 46.42B | 1.54B 339M 294M 275M 251M 472M 32.32B 479M 3.24B 1.26B 16.18B 1.27B 1.24B 53.96B |
| Net income | -1.73M -380K -329K -309K -282K -529K -36.27M -537K -3.63M -1.42M -18.16M -1.43M -1.4M -60.55M | 2.18M 481K 416K 390K 356K 669K 45.84M 679K 4.59M 1.79M 22.95M 1.8M 1.77M 76.53M |
| Net Debt | 143M 31.4M 27.2M 25.49M 23.25M 43.71M 2.99B 44.38M 300M 117M 1.5B 118M 115M 5B | 111M 24.47M 21.2M 19.86M 18.12M 34.06M 2.33B 34.58M 234M 91.32M 1.17B 91.87M 89.88M 3.9B |
Employees
-
Sector
Drug Retailers
Calendar
Select your edition
All financial news and data tailored to specific country editions
